| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $890.6M | -24.7% |
| Cost of Revenue | $694.4M | -16.7% |
| Gross Profit | $196.2M | -44.0% |
| R&D Expense | $144.1M | -13.5% |
| SG&A Expense | $109.1M | -7.6% |
| Operating Income | -$264.1M | -9.9% |
| Interest Expense | $10.6M | — |
| Pre-tax Income | -$293.1M | -12.0% |
| Income Tax | $11.7M | -52.6% |
| Net Income | -$304.7M | -6.4% |
| EPS (Basic) | -$11.01 | -4.7% |
| EPS (Diluted) | -$11.01 | -4.7% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.1M | +57.0% |
| Accounts Receivable | $79.4M | +20.2% |
| Inventory | $152.5M | -46.5% |
| Current Assets | $465.5M | -11.9% |
| Total Assets | $733.7M | -12.2% |
| Current Liabilities | $287.1M | -3.1% |
| Total Liabilities | $537.2M | +49.3% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$114.8M | -27.5% |
| Capital Expenditures | $2.9M | -76.8% |
| Investing Cash Flow | -$3.1M | -237.7% |
| Financing Cash Flow | $185.4M | +6196.5% |
| Free Cash Flow | -$117.7M | -15.0% |
| Stockholders' Equity |
| $196.5M |
| -58.7% |